Company / Working Capital per Share
BioLife Solutions, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.33
FY2025
5-year range
$1.79 / $2.52
FY2021-FY2025
Trend
-7.3%
vs FY2024
Sector context
#118 of 163
Health Care
What the data says
At $2.33, BioLife Solutions, Inc.'s working capital per share ranks #118 of 163 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $0.28 in FY2016 to $3.63 in FY2020.
Based on SEC 10-K filings.
2.33 in FY2025 with a 5-year CAGR of -8.5%.
Improved from $1.79 to $2.33 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +2.3%
- 5-Year CAGR
- -8.5%
- 10-Year CAGR
- -
Sector benchmark
#118 of 163 in Health CareTop 72% of 163This company $2.33 Sector average $24.09
▼
-90.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 7.3% year-over-year.
- Ranks #118 out of 163 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.33 | -7.3% |
| FY2024 | $2.52 | +40.4% |
| FY2023 | $1.79 | -17.7% |
| FY2022 | $2.18 | +0.6% |
| FY2021 | $2.17 | -40.3% |
| FY2020 | $3.63 | +329.7% |
| FY2019 | $0.85 | +38.5% |
| FY2018 | $0.61 | -6.8% |
| FY2017 | $0.65 | +133.1% |
| FY2016 | $0.28 | -35.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026